Doxorubicin's cardiotoxicity primarily results from which mechanism?

• A. Inhibition of protein synthesis
• B. Generation of free radicals
• C. Alteration of calcium metabolism
• D. Inhibition of DNA replication

Answer: (B)

Doxorubicin, a widely used chemotherapeutic agent, is known for its efficacy in treating various types of cancer. However, its use is significantly limited by its potential to cause cardiotoxicity. The primary mechanism behind this cardiotoxicity is the generation of free radicals.

When doxorubicin is metabolized in the body, it undergoes redox cycling, which leads to the production of reactive oxygen species (ROS). These free radicals can cause oxidative stress, damaging cellular structures, including lipid membranes, proteins, and DNA within cardiac myocytes. This oxidative damage plays a crucial role in the pathogenesis of doxorubicin-induced cardiotoxicity, leading to inflammation, apoptosis, and ultimately heart failure in some patients.

Understanding this mechanism is essential for developing strategies to mitigate the risk of cardiotoxicity associated with doxorubicin, such as using cardioprotective agents that can scavenge free radicals or limit their formation. This knowledge also illuminates the importance of monitoring cardiac function in patients receiving doxorubicin as part of their cancer treatment regimen.